Journey into tomorrow: cardiovascular wellbeing transformed by nano-scale innovations.
Autor: | Safhi AY; Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia., Albariqi AH; Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia., Sabei FY; Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia., Alsalhi A; Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia., Khalil FMA; King Khalid University, Collage of Science and Art, Department of Biology, Mohayil Asir Abha 61421, Saudi Arabia., Waheed A; Poonch Medical College Kashmir, Pakistan., Arbi FM; Quaid-e-Azam Medical College, Bahawalpur, Punjab 63100, Pakistan., White A; Liaoning Provincial Key Laboratory of Cerebral Diseases, Department of Physiology, Dalian Medical University Liaoning Provence China, PR China., Anthony S; Cardiovascular Center of Excellence at Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA. Electronic address: safir.biotechnologist22@gmail.com., Alissa M; Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Current problems in cardiology [Curr Probl Cardiol] 2024 Apr; Vol. 49 (4), pp. 102428. Date of Electronic Publication: 2024 Feb 02. |
DOI: | 10.1016/j.cpcardiol.2024.102428 |
Abstrakt: | Worldwide, cardiovascular diseases (CVDs) account for the vast majority of deaths and place enormous financial strains on healthcare systems. Gold nanoparticles, quantum dots, polymeric nanoparticles, carbon nanotubes, and lipids are innovative nanomaterials promising in tackling CVDs. In the setting of CVDs, these nanomaterials actively impact cellular responses due to their distinctive properties, including surface energy and topographies. Opportunities to more precisely target CVDs have arisen due to recent developments in nanomaterial science, which have introduced fresh approaches. An in-depth familiarity with the illness and its targeted mechanisms is necessary to use nanomaterials in CVDs effectively. We support the academic community's efforts to prioritize Nano-technological techniques in addressing risk factors linked with cardiovascular diseases, acknowledging the far-reaching effects of these conditions. The significant impact of nanotechnology on the early detection and treatment of cardiovascular diseases highlights the critical need for novel approaches to this pressing health problem, which is affecting people worldwide. Competing Interests: Declaration of competing interest The authors declared that they have no competing interests among them. (Copyright © 2024. Published by Elsevier Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |